Lucas McKnight, MD

Article
DOACs Versus LMWH and Recurrent VTE in Patients with Cancer
March 1, 2024
Clinical question: Are direct oral anticoagulants (DOACs) acceptable compared to low-molecular-weight heparin (LMWH) for preventing venous thromboembolism (VTE) with a safe bleeding risk in cancer...